[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

US20140142489A1 - Sterilant system - Google Patents

Sterilant system Download PDF

Info

Publication number
US20140142489A1
US20140142489A1 US14/165,076 US201414165076A US2014142489A1 US 20140142489 A1 US20140142489 A1 US 20140142489A1 US 201414165076 A US201414165076 A US 201414165076A US 2014142489 A1 US2014142489 A1 US 2014142489A1
Authority
US
United States
Prior art keywords
reagent
fabric
wipe
sterilant system
sterilant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/165,076
Inventor
Bruce Philip Green
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tristel PLC
Original Assignee
Tristel PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tristel PLC filed Critical Tristel PLC
Priority to US14/165,076 priority Critical patent/US20140142489A1/en
Publication of US20140142489A1 publication Critical patent/US20140142489A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/01—Non-adhesive bandages or dressings
    • A61F13/01008—Non-adhesive bandages or dressings characterised by the material
    • A61F13/01017—Non-adhesive bandages or dressings characterised by the material synthetic, e.g. polymer based
    • A61F13/00017—
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A—HUMAN NECESSITIES
    • A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
    • A47L—DOMESTIC WASHING OR CLEANING; SUCTION CLEANERS IN GENERAL
    • A47L13/00—Implements for cleaning floors, carpets, furniture, walls, or wall coverings
    • A47L13/10—Scrubbing; Scouring; Cleaning; Polishing
    • A47L13/50—Auxiliary implements
    • A47L13/51—Storing of cleaning tools, e.g. containers therefor

Definitions

  • the present invention relates to a two-part sterilant system, notably to a system for producing chlorine dioxide (ClO 2 ).
  • the invention is particularly for use in sterilising medical supplies and equipment, but it is not limited to these uses.
  • Two-part sterilising solutions are used in applications where the active sterilising ingredient is unstable over time.
  • the solution is therefore prepared in situ shortly before it is to be used.
  • a particularly important sterilising agent is chlorine dioxide, which may be formed from mixtures of various reagents including: chlorite and acid; chlorate, peroxide and acid; and chlorite, hypochlorite, and a suitable buffer.
  • Chlorine dioxide has excellent sterilising and bactericidal properties, and oral ingestion in man and animals has been shown to be relatively safe.
  • a two-part sterilant system comprising:
  • the term “fluid” is used herein to include liquids, foams, sprays, pastes, aerosols, powders, sols and gels. It is particularly preferred that the first part is dispensed as a foam or a spray to facilitate its coverage of a desired area of the fabric member.
  • the dispenser may have a relatively large dispensing head, for supplying the fluid over all or a substantial part of a surface of the fabric member.
  • the dispensing head may take the form of a rose or sprinkler with a multitude of small orifices to spread the fluid over the fabric member.
  • the pump dispenser is preferably a trigger-operated dispenser, both for convenience and to facilitate the dispensing of metered quantities.
  • other pump dispensers could be used, for example, a squeeze bottle with a suitable spray or foam nozzle.
  • the invention will, for convenience, be described hereinafter with reference to the use of a trigger-operated dispenser, but it is to be understood that it is not limited to this embodiment.
  • the dispenser comprises a sprayer apparatus that provides the first part as a foam so that it is at least partly form-retaining and can be readily seen and manipulated.
  • a sprayer apparatus that provides the first part as a foam so that it is at least partly form-retaining and can be readily seen and manipulated.
  • providing the first part in a foam may have the beneficial effect of reducing the odour of chlorine dioxide when the wipe is activated.
  • the trigger sprayer may include a mixing chamber to facilitate mixing of the first part with air, for example as described in U.S. Pat. No. 5,337,929.
  • the fabric members may be formed from any suitable fabrics, either woven or non-woven. They may be of natural or man-made fibres, for example polyester, cotton, cellulose or mixtures thereof. Other suitable fabrics will be well known to those skilled in the textile or fabric arts.
  • the fabric member may comprise a fabric wipe or cloth, or a gauze, pad, or other wound dressing material. Once prepared, the fabric member will have biocidal properties and may be used to dress wounds, ulcers, or the like while promoting a sterile local environment around the wound. For convenience, the invention will be described hereinafter with reference to the use of a fabric wipe, but it is to be understood that the invention is not limited to this embodiment.
  • a sterilising wipe may readily be prepared by applying the first part to the wipe.
  • the user may fold the wipe or rub two halves together to facilitate mixing.
  • the wipes are particularly useful for cleaning, disinfecting, and sterilising surfaces and equipment, notably in a medical environment.
  • the first part may include a coloured component so that a visual indication of the coverage of the wipe with the first part can be made.
  • the indicator may be a pH-sensitive indicator.
  • Suitable indicators are well known to those skilled in the art, non-limiting examples including: phenol red, litmus, thymol blue, pentamethoxy red, tropeolin OO, 2,4-dinitrophenol, methyl yellow, methyl orange, bromophenol blue, tetrabromophenol blue, alizarin sodium sulphonate, ⁇ -naphthyl red, p-ethoxychrysoidine, bromocresol green, methyl red, bromocresol purple, chlorophenyl red, bromothymol blue, p-nitrophenol, azolitmin, neutral red, rosalic acid, cresol red, ⁇ -naphtholphthalein, tropeolin OOO, phenolphthalein, ⁇ -na
  • one or more fluorescent additives may be included so that the mixture fluoresces to indicate mixing.
  • suitable fluorescing agents include: 4-methylumbelliferone, 3,6-dihydroxanthone, quinine, thioflavin, 1-napthol, harmine, coumarin, acridine orange, cotarmine, and mixtures thereof.
  • the indicator (colour change or fluorescent) may be included in either part. Preferred proportions by weight are about 0.1 to 10%, notably about 0.5 to 2%.
  • the carrier mediums may be fluids such as liquids or sols, or they may be more form-retaining or viscous compositions such as gels or pastes. It is preferred that at least one reagent is present in an aqueous fluid, although other additives may of course be present. Preferably both reagents are put up in aqueous fluids.
  • the trigger-operated dispenser may be a conventional atomiser or foamer, or other manual pump in which the contents are expelled manually by operation of the trigger by the user.
  • the dispenser may contain a propellant to dispense the contents when operation of the trigger opens a valve, as is well known in applications such as shaving foam canisters and the like. Suitable dispensers will be well known to those skilled in the art.
  • the preferred sterilising agent is chlorine dioxide, which may be formed from suitable known reagents.
  • one reagent is a chlorite (notably sodium chlorite) and the other is an acid, preferably with a buffer.
  • Suitable acids include lactic acid, citric acid, boric acid, phosphoric acid, acetic acid, sorbic acid, ascorbic acid, hydrochloric acid or mixtures thereof.
  • a mixture of acids is used, notably a mixture of citric, sorbic and boric acids.
  • a particularly preferred system is as described in EP 0 785 719, with the corrosion inhibitors optionally not included, and with other additives as desired for particular applications.
  • optional additives include foam-promoting agents or stabilisers, humectants, essential oils and fragrances.
  • Other sterilising agents may also be employed; for example chlorine or oxygen.
  • Chlorine may be produced by reaction between a hypochlorite such as sodium hypochlorite, and a suitable acid or buffer.
  • Oxygen may be produced by reaction between a peroxide and a catalyst such as catalase, optionally in the presence of a buffer.
  • the invention will be described with reference to chlorine dioxide as the sterilising agent.
  • Suitable foam promoters will be well known to those skilled in the art.
  • Non-limiting examples include: sodium laureth sulphate, ammonium lauryl sulphate, cocamide DEA, cocamidopropyl betaine, sodium lauryl sarcosinate, cocamidopropylamine oxide, monoethanolamine lauryl sulphate, cocamidopropyl hydroxysultaine, cocoyl sarcosinate.
  • Anionic, cationic, non-ionic and amphoteric surfactants may be employed depending on the chemistry of the reagents.
  • the foam promoters are selected to provide a stable foam structure.
  • the foam promoter may comprise from about 0.1 to 50% by weight of the first part, notably from about 1 to 10%, preferably from about 3 to 6%.
  • Suitable foam stabilisers well known to those skilled in the art may also be used, in proportions similar to those for the foam-promoters.
  • Non-limiting examples include: alkanolamides, for example monoethanolamides and diethanolamides, amine oxides, betaines, protein hydrolysates and cellulose derivatives such as carboxymethylcellulose.
  • a humectant is included in at least one of the first and second parts.
  • Humectants serve to reduce the rate of evaporation of components and improve product feel if direct skin contact is involved. We have found that the use of a humectant reduces the volatility of chlorine dioxide, which reduces the odour of chlorine dioxide and prolongs the life of the activated mixture.
  • suitable humectants include sodium lactate and polyols, for example glycerine, sorbitol, propylene glycol, diethylene glycol and ethylene glycol.
  • the humectant may be present in any desired amount, particularly from about 0.1 to 50% by weight, notably from about 0.5 to 10%, preferably from about 1 to 3%.
  • one of the reagents is basic or oxidising, for example sodium chlorite
  • this reagent is provided in the trigger dispenser rather than in the wipe, because such reagents may react with the fabric over time.
  • the optional humectant is included in the first part, with the sodium chlorite or other first reagent.
  • the first and/or second part may further include a biocide to ensure that, in the event of poor mixing of the parts, a biocidal effect is still present.
  • the first and/or second part may also include a preservative.
  • Equal weights of the first part and the second part may provide, when mixed, a sterilising composition having a pH of from 1.0 to 10.5, but it is preferred that the composition has a pH of from 4.5 to 6.5 as this may result in a more stable compound.
  • a plurality of fabric members may be provided in a single resealable container, for example a canister with a lid, or a resealable sachet.
  • each fabric member is provided in its own sachet which may be factory-sealed and disposed of after use.
  • each sealed sachet contains a single fabric wipe.
  • FIG. 1 shows a trigger sprayer for use in a sterilant system in accordance with an embodiment of the present invention
  • FIGS. 2 and 4 show an canister of sterilising wipes, respectively open and closed, for use in a sterilant system in accordance with an embodiment of the present invention
  • FIG. 3 shows an alternative trigger sprayer for use in a sterilant system in accordance with an alternative embodiment of the invention.
  • FIG. 5 illustrates a sterilant system in accordance with a further embodiment of the invention.
  • the trigger sprayer shown in FIG. 1 is of a construction well known per se.
  • the sprayer comprises a body 2 connected to a sprayer head 4 by an internally screw-threaded connector ring 14 .
  • a spray nozzle 10 in the head is connected to an aqueous liquid 12 by means of a dip tube 6 .
  • a user dispenses the liquid 12 through the nozzle 10 by operation of a trigger 8 . Rotation of the nozzle allows the user to dispense the fluid as either a spray of fine droplets or as a foam.
  • the liquid 12 (first part) comprises 0.75% of a first reagent (sodium chlorite), 3.0% foam promoter (Cocamidopropyl Betaine). The remainder is deionised water. In this specification, all parts are by weight unless otherwise indicated. Operation of the trigger 8 dispenses the first part 12 as a foam.
  • a first reagent sodium chlorite
  • foam promoter Cocamidopropyl Betaine
  • FIG. 3 An alternative design of pump dispenser 2 is illustrated in FIG. 3 .
  • the trigger 8 is formed integrally with the nozzle 10 . Depressing the trigger 8 dispenses a portion of the fluid contents as a foam (referred to as the ‘Activator Foam’ because it activates the sterilising powers of a sterilising wipe).
  • a protective cap 26 is provided to cover the nozzle 10 and trigger 8 when not in use.
  • a sealable container 20 is also of a construction well known per se.
  • the container 20 is a hollow cylinder fitted with a cap 22 .
  • the container 20 contains a roll of interleaved fabric sheets 18 .
  • the fabric sheets 18 are to be used as sterilising wipes, but it will be understood that the sheets 18 could also be used for other applications such as biocidal wound-dressings.
  • the cap 22 has a central opening through which a tip of the central wipe 18 is disposed. By pulling the central wipe 18 , a user may remove this wipe from the container, leaving the next wipe in its place.
  • a stopper 16 is provided on the cap 22 for releasably sealing the container 20 .
  • the wipes 18 are impregnated with an aqueous acid solution (second part).
  • the acid solution comprises 0.5% citric acid, 0.05% sorbic acid, 0.05% boric acid.
  • the solution also comprises 0.35% of a buffer (trisodium phosphate).
  • the solution also comprises 0.25% Trisodium Citrate, 1.0% glycerine, 0.1% Benzotriazole, 0.1% Sodium Molybdate and 0.3% Sodium Nitrate. The remainder is deionised water.
  • the pump dispenser 2 and container 20 together comprise the sterilant system.
  • a user removes an impregnated wipe 18 from the container 20 , and applies a portion of foam from the sprayer 2 to the wipe 18 .
  • the user may fold the wipe in half and crush or rub the folded wipe before opening it out.
  • one of the components is provided with a pH-sensitive indicator which changes colour or becomes coloured when adequate mixing has occurred, thereby indicating that sufficient ClO 2 has been generated in the wipe.
  • the sterilising wipe may be used for a number of applications, including wiping surfaces and sterilising medical equipment such as endoscopes.
  • each sterilising wipe 18 is provided in its own sealed container 20 , in this example a sachet.
  • the sterilant system comprises a box 28 of sterilising wipes 18 in individual sachets 20 .
  • Each sachet 20 may be factory sealed and may be disposed of after the wipe has been removed.
  • the foam pump dispenser 2 is also provided in the box 28 of sterilising wipe sachets 20 .
  • Sterilant wipes in accordance with one embodiment of the invention were tested and compared with conventional wipes saturated with isopropanol (IPA), a general-purpose detergent, and sterile deionised water.
  • IPA isopropanol
  • the test method to evaluate effectiveness of the wipes in killing/removing test organisms dried onto test surfaces involved the following steps.
  • test surface Inoculate the test surface with 0.5 ml of test organism suspension.
  • test surface was inoculated with 1 ⁇ 10 8 spores.
  • a wiping time of 60 seconds achieved better results than a wiping time of 30 seconds, which in turn achieved better results than a wiping time of 15 seconds.
  • a wipe containing 200 or 300 ppm may be useful, as may mixing times of 15 or 30 seconds (or, clearly, any intermediate times). However, it is preferred that wiping times longer than 15 seconds are employed.
  • Solution A (Wipe) Formulation: Actual % Ingredients w/w Tolerance 1 Citric acid 0.50% +/ ⁇ 0.60-0.40% C.A.S. 77-92-9 2 Sorbic acid 0.005% +/ ⁇ 0.006-0.004% C.A.S. 3 Boric acid 0.005% +/ ⁇ 0.006-0.0040 C.A.S. 10043-35-3 4 Trisodium citrate 0.25% +/ ⁇ 0.30-0.20% C.A.S. 68-04-02 5 Trisodium phosphate 0.35% +/ ⁇ 0.45-0.25% C.A.S. 10101-89-0 6 Glycerin 1.00% +/ ⁇ 1.10-0.90% C.A.S.
  • Solution B Formulation: Actual % Ingredients w/w Tolerance 1 Sodium chlorite (25% solution) 0.75% +/ ⁇ 0.85-0.65% 2 Cocamidopropyl betaine 3.00% +/ ⁇ 3.10-2.90% 3 Indicator/colour solution 0.60% +/ ⁇ 0.07-0.50% (Indicator is cosmetic yellow, No. 5, cl 19140 at 1% solution- 0.6%) 4 Preservative 0.15% +/ ⁇ 0.20-0.10% (Euxyl K 100) 5 Deionised Water (Purified) 95.50% +/ ⁇ C.A.S. 7732-18-5 Balance
  • Wipes were prepared fresh as required by squirting foam onto a wipe and then scrunching the wipe with the fingers to mix the reagents to form ClO 2 .
  • a suspension containing approximately 10 8 spores/ml was prepared by the method of Beeby & Whitehouse.
  • a 1 in 10 dilution in sterile distilled water was prepared to produce a suspension containing approximately 10 7 spores/ml.
  • a culture containing approximately 10 8 cells/ml was prepared by inoculating a tube of nutrient broth and incubating for 18 h at 37° C.
  • the insertion tube was 1 metre long, in good condition, with clear markings.
  • the test site used was the 10 cm section between the 30 and 40 markings.
  • Wipe test site for the prescribed wipe time (30 sec) as follows: Wrap wipe loosely around the insertion tube and then wipe up and down the test site repeatedly.
  • Hospec wipe Kimberley Clark Medical Wipe immersed in 1% Hospec and then squeezed to remove excess solution.
  • ClO 2 wipes were completely effective against both B. subtilis spores and P. aeruginosa cells. No spores or cells were recovered in duplicate experiments.
  • IPA wipes exhibited good activity against P. aeruginosa cells but did not eliminate all of the test cells—40 viable cells were recovered from the test site on the insertion tube.
  • IPA wipes were ineffective against B. subtilis spores. IPA proved less effective than 1% Hospec or water which may be attributable to the coagulant properties of alcohol (fixing spores on the test site).
  • Wipes saturated with water were ineffective against either B. subtilis spores or P. aeruginosa cells.
  • test method was used to evaluate the effectiveness of ClO 2 Wipes in killing/removing test-organisms dried onto test surfaces.
  • the test method involves the following steps:
  • test surface with 4.5 ml of test organism suspension.
  • Methicillin Resistant Staphylococcus aureus (MRSA): a clinical isolate from the Royal Preston Hospital.
  • test surface was inoculated with >10 9 bacterial cells: 4.5 ml of an overnight culture in Nutrient Broth.
  • test surface with 1.0 ml of aqueous spore suspension.
  • control wipe a Medical Wipe saturated with sterile water.
  • Bacillus subtilis var. niger NCTC 10073 A spore suspension was prepared by the method of Beeby & Whitehouse.
  • test surface was inoculated with (a) 10 6 spores, and (b) 10 8 spores.
  • the inoculated instrument tray was allowed to dry out naturally at room temperature for 24 h in a dark cupboard.
  • ClO 2 Wipes were effective in killing/removing spores dried out for 24 h at room temperature on the stainless steel test surface. With the 10 6 inoculum, no spores were recovered from either the surface or wipe which represents a 3-4 log ic reduction on both the surface and wipe. With the 108 inoculum, a 2-3 log 10 reduction of spores was achieved on the surface and a 3-4 log 10 reduction on the wipe.
  • the invention provides a sterilant system which can be prepared in situ and which provides bactericidal, fungicidal, virucidal, and sporicidal fabrics.
  • the system is particularly useful for sterilising wipes and for the dressing of wounds and ulcers.
  • acetic anhydride and ascorbic acid may advantageously be employed together as additives in Solution A.
  • a preferred concentration for each additive is 0.4%

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Inorganic Chemistry (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

A two-part sterilant system comprises a first part comprising a first reagent in a carrier medium and a second part which is miscible with the first part and which comprises a second reagent in a carrier medium. The first reagent and the second reagent will react when mixed to provide a sterilising composition. The first part is contained in a pump dispenser (2) whereby it may be dispensed as a fluid, and the second part is absorbed or impregnated in at least one fabric member (18) in a sealed container (20).

Description

  • This application is a continuation application of U.S. application Ser. No. 10/935,651, filed 7 Sep. 2004, and which application is incorporated herein by reference. To the extent appropriate, a claim of priority is made to U.S. application Ser. No. 10/935,651.
    • FIELD OF THE INVENTION
  • The present invention relates to a two-part sterilant system, notably to a system for producing chlorine dioxide (ClO2). The invention is particularly for use in sterilising medical supplies and equipment, but it is not limited to these uses.
    • BACKGROUND TO THE INVENTION
  • Two-part sterilising solutions are used in applications where the active sterilising ingredient is unstable over time. The solution is therefore prepared in situ shortly before it is to be used. A particularly important sterilising agent is chlorine dioxide, which may be formed from mixtures of various reagents including: chlorite and acid; chlorate, peroxide and acid; and chlorite, hypochlorite, and a suitable buffer. Chlorine dioxide has excellent sterilising and bactericidal properties, and oral ingestion in man and animals has been shown to be relatively safe.
  • The cleaning of endoscopes and other medical equipment with suitable chlorine dioxide solutions is known from earlier patents in the name of the present inventor, for example, European Patent Number 0 785 719 and U.S. Pat. Nos. 5,696,046 and 6,007,772, the contents of which are hereby incorporated by reference.
  • It is not always convenient to mix up batches of solutions for use in sterilising equipment. For wiping down (rather than thoroughly cleaning inside and out) of endoscopes and probes, wipes of alcohol, general-purpose detergent, or soapy water are generally used, but these are not as effective as chlorine dioxide. It is desirable to be able readily to make up small quantities of two-component sterilising agents when desired and to be able to make such agents up in a form in which they may be readily handled for a particular application.
    • SUMMARY OF THE INVENTION
  • According to a first aspect of the present invention there is provided a two-part sterilant system comprising:
  • (a) a first part comprising a first reagent in a carrier medium; and
    (b) a second part which is miscible with the first part and which comprises a second reagent in a carrier medium;
      • wherein the first reagent and the second reagent will react when mixed to provide a sterilising composition;
      • characterised in that the first part is contained in a pump dispenser whereby it may be dispensed as a fluid, and in that the second part is absorbed or impregnated in at least one fabric member in a sealed container.
  • The term “fluid” is used herein to include liquids, foams, sprays, pastes, aerosols, powders, sols and gels. It is particularly preferred that the first part is dispensed as a foam or a spray to facilitate its coverage of a desired area of the fabric member. Optionally, the dispenser may have a relatively large dispensing head, for supplying the fluid over all or a substantial part of a surface of the fabric member. For example, the dispensing head may take the form of a rose or sprinkler with a multitude of small orifices to spread the fluid over the fabric member.
  • The pump dispenser is preferably a trigger-operated dispenser, both for convenience and to facilitate the dispensing of metered quantities. However, other pump dispensers could be used, for example, a squeeze bottle with a suitable spray or foam nozzle. The invention will, for convenience, be described hereinafter with reference to the use of a trigger-operated dispenser, but it is to be understood that it is not limited to this embodiment.
  • By putting up the first part in a trigger-operated dispenser, small quantities may be readily dispensed without risk of spillage. Preferably the dispenser comprises a sprayer apparatus that provides the first part as a foam so that it is at least partly form-retaining and can be readily seen and manipulated. We have also found that providing the first part in a foam may have the beneficial effect of reducing the odour of chlorine dioxide when the wipe is activated. The invention will for convenience be described with reference to this preferred embodiment, but it will be understood that the invention is not limited to this embodiment.
  • The trigger sprayer may include a mixing chamber to facilitate mixing of the first part with air, for example as described in U.S. Pat. No. 5,337,929.
  • The fabric members may be formed from any suitable fabrics, either woven or non-woven. They may be of natural or man-made fibres, for example polyester, cotton, cellulose or mixtures thereof. Other suitable fabrics will be well known to those skilled in the textile or fabric arts.
  • The fabric member may comprise a fabric wipe or cloth, or a gauze, pad, or other wound dressing material. Once prepared, the fabric member will have biocidal properties and may be used to dress wounds, ulcers, or the like while promoting a sterile local environment around the wound. For convenience, the invention will be described hereinafter with reference to the use of a fabric wipe, but it is to be understood that the invention is not limited to this embodiment.
  • By providing the second part absorbed in a fabric wipe, a sterilising wipe may readily be prepared by applying the first part to the wipe. The user may fold the wipe or rub two halves together to facilitate mixing. The wipes are particularly useful for cleaning, disinfecting, and sterilising surfaces and equipment, notably in a medical environment.
  • The first part may include a coloured component so that a visual indication of the coverage of the wipe with the first part can be made.
  • In a preferred embodiment, at least one of the first and second parts is provided with an indicator reagent that changes colour to show that sufficient mixing has taken place. Where the first part and the second part are of different pH, the indicator may be a pH-sensitive indicator. Suitable indicators are well known to those skilled in the art, non-limiting examples including: phenol red, litmus, thymol blue, pentamethoxy red, tropeolin OO, 2,4-dinitrophenol, methyl yellow, methyl orange, bromophenol blue, tetrabromophenol blue, alizarin sodium sulphonate, α-naphthyl red, p-ethoxychrysoidine, bromocresol green, methyl red, bromocresol purple, chlorophenyl red, bromothymol blue, p-nitrophenol, azolitmin, neutral red, rosalic acid, cresol red, α-naphtholphthalein, tropeolin OOO, phenolphthalein, α-naphtholbenzein, thymolphthalein, nile blue, alizarin yellow, diazo violet, tropeolin O, nitramine, Poirrer's blue, trinitrobenzoic acid, and mixtures thereof. It is preferred that the indicator is selected so that both parts are separately colourless and the colour develops when the two parts are mixed.
  • Alternatively, or additionally, one or more fluorescent additives may be included so that the mixture fluoresces to indicate mixing. Non-limiting examples of suitable fluorescing agents include: 4-methylumbelliferone, 3,6-dihydroxanthone, quinine, thioflavin, 1-napthol, harmine, coumarin, acridine orange, cotarmine, and mixtures thereof.
  • The indicator (colour change or fluorescent) may be included in either part. Preferred proportions by weight are about 0.1 to 10%, notably about 0.5 to 2%.
  • The carrier mediums may be fluids such as liquids or sols, or they may be more form-retaining or viscous compositions such as gels or pastes. It is preferred that at least one reagent is present in an aqueous fluid, although other additives may of course be present. Preferably both reagents are put up in aqueous fluids.
  • The trigger-operated dispenser may be a conventional atomiser or foamer, or other manual pump in which the contents are expelled manually by operation of the trigger by the user. Alternatively, the dispenser may contain a propellant to dispense the contents when operation of the trigger opens a valve, as is well known in applications such as shaving foam canisters and the like. Suitable dispensers will be well known to those skilled in the art.
  • The preferred sterilising agent is chlorine dioxide, which may be formed from suitable known reagents. In a preferred embodiment one reagent is a chlorite (notably sodium chlorite) and the other is an acid, preferably with a buffer. Suitable acids include lactic acid, citric acid, boric acid, phosphoric acid, acetic acid, sorbic acid, ascorbic acid, hydrochloric acid or mixtures thereof. In a preferred embodiment a mixture of acids is used, notably a mixture of citric, sorbic and boric acids.
  • A particularly preferred system is as described in EP 0 785 719, with the corrosion inhibitors optionally not included, and with other additives as desired for particular applications. In addition to suitable indicators, optional additives include foam-promoting agents or stabilisers, humectants, essential oils and fragrances. Other sterilising agents may also be employed; for example chlorine or oxygen. Chlorine may be produced by reaction between a hypochlorite such as sodium hypochlorite, and a suitable acid or buffer. Oxygen may be produced by reaction between a peroxide and a catalyst such as catalase, optionally in the presence of a buffer. For convenience hereinafter, the invention will be described with reference to chlorine dioxide as the sterilising agent.
  • Suitable foam promoters will be well known to those skilled in the art. Non-limiting examples include: sodium laureth sulphate, ammonium lauryl sulphate, cocamide DEA, cocamidopropyl betaine, sodium lauryl sarcosinate, cocamidopropylamine oxide, monoethanolamine lauryl sulphate, cocamidopropyl hydroxysultaine, cocoyl sarcosinate. Anionic, cationic, non-ionic and amphoteric surfactants may be employed depending on the chemistry of the reagents. The foam promoters are selected to provide a stable foam structure. The foam promoter may comprise from about 0.1 to 50% by weight of the first part, notably from about 1 to 10%, preferably from about 3 to 6%.
  • Suitable foam stabilisers well known to those skilled in the art may also be used, in proportions similar to those for the foam-promoters. Non-limiting examples include: alkanolamides, for example monoethanolamides and diethanolamides, amine oxides, betaines, protein hydrolysates and cellulose derivatives such as carboxymethylcellulose.
  • In a preferred embodiment, a humectant is included in at least one of the first and second parts. Humectants serve to reduce the rate of evaporation of components and improve product feel if direct skin contact is involved. We have found that the use of a humectant reduces the volatility of chlorine dioxide, which reduces the odour of chlorine dioxide and prolongs the life of the activated mixture. Non-limiting examples of suitable humectants include sodium lactate and polyols, for example glycerine, sorbitol, propylene glycol, diethylene glycol and ethylene glycol. The humectant may be present in any desired amount, particularly from about 0.1 to 50% by weight, notably from about 0.5 to 10%, preferably from about 1 to 3%.
  • Where one of the reagents is basic or oxidising, for example sodium chlorite, it is particularly preferred that this reagent is provided in the trigger dispenser rather than in the wipe, because such reagents may react with the fabric over time. Preferably the optional humectant is included in the first part, with the sodium chlorite or other first reagent.
  • The first and/or second part may further include a biocide to ensure that, in the event of poor mixing of the parts, a biocidal effect is still present. The first and/or second part may also include a preservative.
  • Equal weights of the first part and the second part may provide, when mixed, a sterilising composition having a pH of from 1.0 to 10.5, but it is preferred that the composition has a pH of from 4.5 to 6.5 as this may result in a more stable compound.
  • A plurality of fabric members may be provided in a single resealable container, for example a canister with a lid, or a resealable sachet. In a preferred embodiment, each fabric member is provided in its own sachet which may be factory-sealed and disposed of after use. In a particularly preferred embodiment, each sealed sachet contains a single fabric wipe.
  • Other aspects and benefits of the invention will appear in the following specification, drawings and claims.
    • BRIEF DESCRIPTION OF THE DRAWINGS
  • The invention will now be further described, by way of example, with reference to the following drawings in which:
  • FIG. 1 shows a trigger sprayer for use in a sterilant system in accordance with an embodiment of the present invention;
  • FIGS. 2 and 4 show an canister of sterilising wipes, respectively open and closed, for use in a sterilant system in accordance with an embodiment of the present invention;
  • FIG. 3 shows an alternative trigger sprayer for use in a sterilant system in accordance with an alternative embodiment of the invention; and
  • FIG. 5 illustrates a sterilant system in accordance with a further embodiment of the invention.
    •  DETAILED DESCRIPTION
  • The trigger sprayer shown in FIG. 1 is of a construction well known per se. The sprayer comprises a body 2 connected to a sprayer head 4 by an internally screw-threaded connector ring 14. A spray nozzle 10 in the head is connected to an aqueous liquid 12 by means of a dip tube 6. A user dispenses the liquid 12 through the nozzle 10 by operation of a trigger 8. Rotation of the nozzle allows the user to dispense the fluid as either a spray of fine droplets or as a foam.
  • In the present example, the liquid 12 (first part) comprises 0.75% of a first reagent (sodium chlorite), 3.0% foam promoter (Cocamidopropyl Betaine). The remainder is deionised water. In this specification, all parts are by weight unless otherwise indicated. Operation of the trigger 8 dispenses the first part 12 as a foam.
  • An alternative design of pump dispenser 2 is illustrated in FIG. 3. The trigger 8 is formed integrally with the nozzle 10. Depressing the trigger 8 dispenses a portion of the fluid contents as a foam (referred to as the ‘Activator Foam’ because it activates the sterilising powers of a sterilising wipe). A protective cap 26 is provided to cover the nozzle 10 and trigger 8 when not in use.
  • Turning now to FIGS. 2 and 4, a sealable container 20 is also of a construction well known per se. The container 20 is a hollow cylinder fitted with a cap 22. The container 20 contains a roll of interleaved fabric sheets 18. In this example, the fabric sheets 18 are to be used as sterilising wipes, but it will be understood that the sheets 18 could also be used for other applications such as biocidal wound-dressings.
  • The cap 22 has a central opening through which a tip of the central wipe 18 is disposed. By pulling the central wipe 18, a user may remove this wipe from the container, leaving the next wipe in its place. A stopper 16 is provided on the cap 22 for releasably sealing the container 20.
  • In this example, the wipes 18 are impregnated with an aqueous acid solution (second part). In this example, the acid solution comprises 0.5% citric acid, 0.05% sorbic acid, 0.05% boric acid. The solution also comprises 0.35% of a buffer (trisodium phosphate). The solution also comprises 0.25% Trisodium Citrate, 1.0% glycerine, 0.1% Benzotriazole, 0.1% Sodium Molybdate and 0.3% Sodium Nitrate. The remainder is deionised water.
  • The pump dispenser 2 and container 20 together comprise the sterilant system. To prepare a sterilising wipe, a user removes an impregnated wipe 18 from the container 20, and applies a portion of foam from the sprayer 2 to the wipe 18. To facilitate mixing of the reagents in the foam and the wipe, the user may fold the wipe in half and crush or rub the folded wipe before opening it out. Preferably, one of the components is provided with a pH-sensitive indicator which changes colour or becomes coloured when adequate mixing has occurred, thereby indicating that sufficient ClO2 has been generated in the wipe.
  • Once the sterilising wipe has been prepared, it may be used for a number of applications, including wiping surfaces and sterilising medical equipment such as endoscopes.
  • In the preferred embodiment illustrated in FIG. 5, each sterilising wipe 18 is provided in its own sealed container 20, in this example a sachet. The sterilant system comprises a box 28 of sterilising wipes 18 in individual sachets 20. Each sachet 20 may be factory sealed and may be disposed of after the wipe has been removed. The foam pump dispenser 2 is also provided in the box 28 of sterilising wipe sachets 20.
    • EXPERIMENTAL RESULTS Experiment 1
  • Sterilant wipes in accordance with one embodiment of the invention were tested and compared with conventional wipes saturated with isopropanol (IPA), a general-purpose detergent, and sterile deionised water.
  • The test method to evaluate effectiveness of the wipes in killing/removing test organisms dried onto test surfaces, involved the following steps.
  • 1. Mark out a six inch (30.5 cm) square test area on the test surface.
  • 2. Inoculate the test surface with 0.5 ml of test organism suspension.
  • 3. Spread the inoculum over the test area using a plastic spreader.
  • 4. Allow the inoculum to dry (about 30 minutes).
  • 5. Don a pair of disposable plastic gloves.
  • 6. Prepare a ClO2 wipe in accordance with the invention, using a prescribed mixing time.
  • 7. Wipe the test area for the prescribed wiping time.
  • 8. Place the wipe in 10 ml of universal neutraliser in a Universal bottle (Test Suspension A). Vortex stir to release organisms.
  • 9. Wipe the entire test area with a cotton-tipped swab (thoroughly/10 times).
  • 10. Dip the swab into 10 ml of universal neutraliser in a Universal bottle after each sampling of the test area and rotate the swab against the inner wall of the bottle to release organisms (Test Suspension B).
  • 11. Prepare 5 serial deci-dilutions of Test Suspension A and Test Suspension B in diluent.
  • 12. Inoculate 0.5 ml of each dilution onto a culture plate and spread using a plastic spreader. Incubate the plates and do a viable count.
  • 13. Calculate log10 reductions achieved from the difference in the initial inoculum and the number of test organisms recovered after disinfection with a ClO2 wipe.
  • Test variables were as follows.
    • Test Surface
  • A flat stainless steel instrument tray.
    • Test Organism
  • Spores of Bacillus subtilis var. niger NCTC 10073 freshly prepared by the method of Beeby & Whitehouse.
    • Inoculum
  • The test surface was inoculated with 1×108 spores.
    • Suspending Fluid
  • Sterile deionised water.
    • Disinfectant Concentrations
  • 1. 200 ppm ClO2 (notional)
  • 2. 300 ppm ClO2 (notional).
    • Mixing Times
  • 15+30 seconds.
    • Wiping Times
  • 15+30 +60 seconds.
    • Controls
  • 1.1% Hospec general purpose neutral liquid detergent (Young's Detergents)/Kimcare Medical Wipes (Kimberly-Clark).
  • 2. Sterets Alcowipe: 70% IPA (Seton Prebbles Ltd).
  • 3. Sterile deionised water: Kimcare Medical Wipes (Kimberly-Clark).
  • Results are given in Table 1.
  • TABLE 1
    Mixing Wiping
    Exp. Disinfectant/ time time VC VC
    No. Detergent (seconds) (seconds) Surface Wipe
    1 200 ppm ClO2 15 15 177 143
    2 200 ppm ClO2 15 30 36 14
    3 200 ppm ClO2 15 60 10 8
    4 200 ppm ClO2 30 15 800 300
    5 200 ppm ClO2 30 30 240 27
    6 200 ppm ClO2 30 60 29 26
    7 300 ppm ClO2 15 15 1240 330
    8 300 ppm ClO2 15 30 530 250
    9 300 ppm ClO2 15 60 160 140
    10 300 ppm ClO2 30 15 1450 900
    11 300 ppm ClO2 30 30 30 70
    12 300 ppm ClO2 30 60 20 10
    13 1% Hospec 60 7.3 × 104 4.3 × 105
    14 70% IPA 60 1.9 × 104 3.7 × 104
    15 Deionised H2O 60 2.0 × 105 3.0 × 105
    VC = Viable Count
    • Interpretation of Results
  • 1. Washing/wiping with water, neutral detergent (1% Hospec), or alcohol (70% IPA) were ineffective
  • 2. For the notional 200 ppm ClO2 wipes the best results were obtained with a mixing time of 15 seconds and a wiping time of 60 seconds.
  • 3. For the notional 300 ppm ClO2 wipes the best results were obtained with a mixing time of 30 seconds and a wiping time of 60 seconds.
  • 4. Results for 200 ppm ClO2 (notional) were surprisingly better than results for 300 ppm (notional), except for mixing times of 30 seconds combined with wiping times of at least 30 seconds.
  • 5. A wiping time of 60 seconds achieved better results than a wiping time of 30 seconds, which in turn achieved better results than a wiping time of 15 seconds.
  • 6. Both ClO2 concentrations achieved good results after a wiping time of 60 seconds. The test surface was inoculated with 1×108 spores. After using the ClO2 wipes, surface counts were reduced to 10 and 29 (200 ppm ClO2) and to 160 and 20 (300 ppm ClO2).
  • 7. A wipe containing 200 or 300 ppm may be useful, as may mixing times of 15 or 30 seconds (or, clearly, any intermediate times). However, it is preferred that wiping times longer than 15 seconds are employed.
  • These results were obtained using bacterial spores. It is to be expected that a vegetative bacterium such as MRSA will be much more sensitive, so that lower ClO2 concentrations and/or shorter mixing or wiping times may be effective against such bacteria.
  • Further experiments (2-4) were carried out using 41 gsm spunlace sheets comprised of 50.5% wood pulp and 49.5% PET. The sheets' dimensions were 160 mm×180 mm×0.36 mm. In each experiment the wipes each contained 3 ml of Solution A (formulated as set forth below), made by treating a canister of 50 wipes with 150 ml of Solution A. Each wipe was activated with 1.5 ml of Solution B (formulated as set forth below) from a foam dispenser.
  • Solution A (Wipe)
    Formulation:
    Actual %
    Ingredients w/w Tolerance
    1 Citric acid 0.50% +/−0.60-0.40%
    C.A.S. 77-92-9
    2 Sorbic acid 0.005%  +/−0.006-0.004%
    C.A.S.
    3 Boric acid 0.005%  +/−0.006-0.0040 
    C.A.S. 10043-35-3
    4 Trisodium citrate 0.25% +/−0.30-0.20%
    C.A.S. 68-04-02
    5 Trisodium phosphate 0.35% +/−0.45-0.25%
    C.A.S. 10101-89-0
    6 Glycerin 1.00% +/−1.10-0.90%
    C.A.S. 56-81-5
    7 Benzotriazole 0.10% +/−0.15-0.05%
    C.A.S. 95-14-7
    8 Sodium molybdate 0.10% +/−0.15-0.05%
    C.A.S. 10102-40-6
    9 Sodium nitrate 0.20% +/−0.25-0.15%
    C.A.S. 7631-99-4
    10 Preservative (Paramotol) 0.15% +/−0.20-0.10%
    C.A.S.
    11 Deionised water Balance Balance
    C.A.S. 7732-18-5
  • Solution B (Foam)
    Formulation:
    Actual %
    Ingredients w/w Tolerance
    1 Sodium chlorite (25% solution) 0.75% +/−0.85-0.65%
    2 Cocamidopropyl betaine 3.00% +/−3.10-2.90%
    3 Indicator/colour solution 0.60% +/−0.07-0.50%
    (Indicator is cosmetic yellow,
    No. 5, cl 19140 at 1% solution-
    0.6%)
    4 Preservative 0.15% +/−0.20-0.10%
    (Euxyl K 100)
    5 Deionised Water (Purified) 95.50%  +/−
    C.A.S. 7732-18-5 Balance
    • Experiment 2
  • A study was carried out to compare the effectiveness of (a) ClO2 wipes in accordance with the invention (b) a 70% IPA wipe (c) a neutral detergent wipe and (d) a water wipe in removing and/or killing (1) B. subtilis spores, and (2) P. aeruginosa cells dried onto the insertion tube of a flexible endoscope.
  • Wipes were prepared fresh as required by squirting foam onto a wipe and then scrunching the wipe with the fingers to mix the reagents to form ClO2.
    • EXPERIMENT 2 Test Organisms B. Subtilis NCTC 10073 Spores
  • A suspension containing approximately 108 spores/ml was prepared by the method of Beeby & Whitehouse. A 1 in 10 dilution in sterile distilled water was prepared to produce a suspension containing approximately 107 spores/ml.
  • P. aeruginosa NCTC 6749
  • A culture containing approximately 108 cells/ml was prepared by inoculating a tube of nutrient broth and incubating for 18 h at 37° C.
    • Insertion Tube Used in Experiment 2
  • The insertion tube was 1 metre long, in good condition, with clear markings. The test site used was the 10 cm section between the 30 and 40 markings.
    • Test Method
  • 1. Immerse a cotton-tipped swab into a suspension of spores or vegetative cells.
  • 2. Inoculate entire surface area of test site with the suspension. Repeat several times. Regarding B. subtilis spores, assume that (1) the volume of inoculum=0.1 ml, and (2) the mortality rate on drying out is zero. Hence the viable count of the inoculum=approximately 106 spores. Regarding P. aeruginosa cells, assume that (1) the volume of inoculum=0.1 ml, and (2) the mortality rate on drying out is 1 log. Hence the viable count of the inoculum=approximately 106 cells.
  • 3. Place inoculated insertion tube across the top of an empty discard jar with the 10 cm test site resting over the centre of the jar. Allow inoculum to dry out (approximately 30 minutes).
  • 4. Don pair of disposable plastic gloves.
  • 5. Prepare a Wipe: ClO2 (scrunch time=15 sec), IPA, Hospec or water.
  • 6. Wipe test site for the prescribed wipe time (30 sec) as follows: Wrap wipe loosely around the insertion tube and then wipe up and down the test site repeatedly.
  • 7. Place the wipe in 20 ml of universal neutraliser in a Universal bottle. Vortex stir to release recovered spores/cells (Test Suspension A).
  • 8. Swab entire test site with a cotton-tipped swab. Dip swab into 10 ml of universal neutraliser in a Universal bottle and rotate swab against the inner wall of the bottle to release recovered spores/cells. Repeat 10 times then break off cotton-tip of swab and leave in the neutraliser. Vortex stir to release recovered spores/cells (Test Suspension B).
  • 9. Prepare 5 serial deci-dilutions of Test Suspension A and Test Suspension B in diluent.
  • 10. Inoculate 0.5 ml of each dilution onto a culture plate and spread using a plastic spreader. Incubate plates. Viable count.
  • 11. Calculate logic reductions achieved from the difference in the number of spores or cells inoculated onto the test site (approximately 106) and the number recovered after cleaning and/or disinfection.
  • Wipes used in Experiment 2
  • 1. ClO2 Wipe (scrunch time=15 seconds).
  • 2. 70% IPA wipe: Azowipe (Vernon Carus).
  • 3. Hospec wipe: Kimberley Clark Medical Wipe immersed in 1% Hospec and then squeezed to remove excess solution.
  • 4. Water wipe: Kimberley Clark Medical Wipe immersed in sterile water and then squeezed to remove excess water.
    • Experiment 2 Results
  • TABLE 2
    Disinfec- Scrunch Wipe Viable Count
    Test tant/de- time time (0.5 ml)
    Exp organism tergent (sec) (sec) Surface Wipe
    1 B. ClO2 15 30 0 0
    2 subtilis ClO2 15 30 0 0
    (repeat)
    3 70% IPA 30 5.0 × 102 2.7 × 103
    4 1% 30 1.5 × 102 2.6 × 103
    Hospec
    5 Water 30 3.0 × 101 2.5 × 103
    6 P. ClO2 15 30 0 0
    7 aeruginosa ClO2 15 30 0 0
    (repeat)
    8 70% IPA 30 2 0
    9 1% 30 6.2 × 103 8.0 × 104
    Hospec
    10 Water 30 2.5 × 104 1.5 × 105
  • TABLE 3
    Total spores/cells
    Disinfectant/ recovered
    Exp Test organism detergent Surface1 Wipe2
    1 B. subtilis ClO2 0 0
    2 ClO2 (repeat) 0 0
    3 70% IPA 1.0 × 104 1.0 × 105
    4 1% Hospec 3.0 × 103 1.0 × 105
    5 Water 6.0 × 102 1.0 × 105
    6 P. aeruginosa ClO2 0 0
    7 ClO2 (repeat) 0 0
    8 70% IPA 4.0 × 101 0
    9 1% Hospec 1.2 × 105 3.2 × 106
    10 Water 5.0 × 105 6.0 × 106
    1Viable count in Table 1 × 20 (0.5 ml of 10 ml neutraliser plated out).
    2Viable count in Table 1 × 40 (0.5 ml of 20 ml neutraliser plated out).
    • Experiment 2 Conclusions
  • 1. ClO2 wipes were completely effective against both B. subtilis spores and P. aeruginosa cells. No spores or cells were recovered in duplicate experiments.
  • 2. IPA wipes exhibited good activity against P. aeruginosa cells but did not eliminate all of the test cells—40 viable cells were recovered from the test site on the insertion tube.
  • 3. IPA wipes were ineffective against B. subtilis spores. IPA proved less effective than 1% Hospec or water which may be attributable to the coagulant properties of alcohol (fixing spores on the test site).
  • 4. Wipes saturated with 1% Hospec were ineffective against either B. subtilis spores or P. aeruginosa cells.
  • 5. Wipes saturated with water were ineffective against either B. subtilis spores or P. aeruginosa cells.
    • Experiment 3 Evaluation of the Effectiveness of Clo2 Wipes in Killing/Removing Methicillin Resistant Staphylococcus Aureus (MRSA) Dried onto a Stainless Steel Test Surface Test Method
  • The following test method was used to evaluate the effectiveness of ClO2 Wipes in killing/removing test-organisms dried onto test surfaces. The test method involves the following steps:
  • 1. Mark out an 18 inch (457.2 mm) square on the test surface.
  • 2. Inoculate test surface with 4.5 ml of test organism suspension.
  • 3. Spread inoculum over 18 inch (457.2 mm) square test area using a plastic spreader.
  • 4. Allow inoculum to dry (30-60 minutes).
  • 5. Don pair of disposable plastic gloves.
  • 6. Prepare a ClO2 Wipe using the prescribed scrunch time (15 seconds).
  • 7. Wipe test area for the prescribed wipe time (30 seconds).
  • 8. Place the ClO2 Wipe in 20 ml of universal neutraliser in a universal bottle. Vortex stir to release organisms. (Test Suspension A).
  • 9. Swab entire test area with a cotton-tipped swab. Dip swab into 10 ml of universal neutraliser in a universal bottle and rotate cotton-tip against the inner wall of the bottle to release organisms. Repeat 10 times. Finally, snap off cotton-tip into the neutraliser. Vortex stir to release organisms. (Test Suspension B).
  • 10. Prepare 5 serial deci-dilutions of Test Suspension A and Test Suspension B in diluent.
  • 11. Inoculate 0.5 ml of each dilution onto a culture plate and spread using a plastic spreader. Incubate plates. Viable count.
  • 12. Calculate logic reductions achieved from the difference in the initial inoculum and the number of test organisms recovered after cleaning/disinfection with a ClO2 Wipe.
  • 13. Repeat above using control wipes (70% IPA, 1% Hospec & sterile water).
    • Variables Selected in Experiment 3 Test Surface
  • A flat stainless steel laboratory bench.
    • Test Organism
  • Methicillin Resistant Staphylococcus aureus (MRSA): a clinical isolate from the Royal Preston Hospital.
    • Inoculum
  • The test surface was inoculated with >109 bacterial cells: 4.5 ml of an overnight culture in Nutrient Broth.
    • Suspending Fluid
  • Nutrient Broth
    • Scrunch Time
  • 15 seconds
    • Wipe Time
  • 30 seconds
    • Controls
  • 1.70% IPA wipe: Azowipe (Vernon Carus).
  • 2.1% Hospec general purpose neutral liquid detergent (Young's Detergents)/Kimcare Medical Wipe (Kimberly-Clark). The wipe was immersed in 1% Hospec and then squeezed with the fingers to remove excess fluid.
  • 3. Sterile deionised water/Kimcare Medical Wipe (Kimberly-Clark). The wipe was immersed in water and then squeezed with the fingers to remove excess fluid.
    • Results
  • TABLE 4
    Mixing Wiping
    Disinfectant/ time time Viable Count
    Exp detergent (sec) (sec) Surface Wipe
    1 ClO2 15 30 0 0
    2 ClO2 (repeat) 15 30 0 0
    3 70% IPA 30 5.5 × 104 9
    4 1% Hospec 30 5.5 × 104 6.0 × 104
    5 Deionised H2O 30 5.7 × 104 5.9 × 104
  • TABLE 5
    Mixing Wiping Total number of
    Disinfectant/ time time organisms recovered
    Exp detergent (sec) (sec) Surface1 Wipe2
    1 ClO2 15 30 0 0
    2 ClO2 15 30 0 0
    (repeat)
    3 70% IPA 30 1.1 × 106 3.6 × 102
    4 1% Hospec 30 1.1 × 106 2.4 × 106
    5 Deionised 30 1.1 × 106 2.4 × 106
    H2O
    1Viable Count in Table 1 × 20 (0.5 ml of 10 ml neutraliser plated out).
    2Viable Count in Table 1 × 40 (0.5 ml of 20 ml neutraliser plated out).
    • Interpretation of Results
  • 1. Wiping with a ClO2 Wipe for 30 seconds was completely effective. No test organisms were recovered from either the test surface or the wipes in duplicate experiments.
  • 2. Wiping the test surface with a 70% IPA wipe (Azowipe) for 30 seconds was ineffective. This could be due to:
  • (a) an exposure time of 30 seconds was not long enough to kill the MRSA
  • (b) the IPA evaporated off the test surface before the minimum exposure time required to kill the MRSA
  • (c) the volume of IPA on the wipe was insufficient to deal with the >109 MRSA dried onto the 18 inch test surface
  • (d) a combination of the above.
  • 3. Only 360 test organisms were recovered from the Azowipe. This could be due to:
    • (a) entrapment of test organisms in the fibres
    • (b) incomplete/slow neutralisation of the residual IPA on the wipe by the neutraliser
    • (c) a combination of the above
  • 4. Wipes saturated with either 1% Hospec or sterile water were ineffective.
    • Experiment 4
  • This experiment was carried out to evaluate the effectiveness of ClO2 Wipes in killing/removing spores of Bacillus subtilis var. niger NCTC 10073 dried out for 24 h at room temperature on a stainless steel test surface.
    • Test Method
  • 1. Mark out a 12 inch (304.8 mm) square on the test surface.
  • 2. Inoculate test surface with 1.0 ml of aqueous spore suspension.
  • 3. Spread inoculum over 12 inch (304.8 mm) square test area using a plastic spreader.
  • 4. Allow inoculum to dry out naturally at room temperature for 24 h.
  • 5. Don pair of disposable plastic gloves.
  • 6. Prepare a ClO2 Wipe using the prescribed scrunch time (15 seconds).
  • 7. Wipe test area for the prescribed wipe time (30 seconds).
  • 8. Place the ClO2 Wipe in 20 ml of universal neutraliser in a universal bottle. Vortex stir to release organisms. (Test Suspension A).
  • 9. Swab entire test area with a cotton-tipped swab. Dip swab into 10 ml of universal neutraliser in a universal bottle and rotate cotton-tip against the inner wall of the bottle to release organisms. Repeat 10 times. Finally, snap off cotton-tip into the neutraliser. Vortex stir to release organisms. (Test Suspension B).
  • 10. Prepare 5 serial deci-dilutions of Test Suspension A and Test Suspension B in diluent.
  • 11. Inoculate 0.5 ml of each dilution onto a culture plate and spread using a plastic spreader.
  • 12. Repeat above using a control wipe (a Medical Wipe saturated with sterile water).
  • 13. Incubate plates. Viable count.
  • 14. Calculate log10 reductions achieved using the ClO2 Wipe from the difference in viable count obtained using the ClO2 Wipe and the control wipe.
    • Variables Selected in Experiment 4 Test Surface
  • A flat stainless steel instrument tray.
    • Test Organism
  • Bacillus subtilis var. niger NCTC 10073. A spore suspension was prepared by the method of Beeby & Whitehouse.
    • Inoculum
  • The test surface was inoculated with (a) 10 6 spores, and (b) 108 spores.
    • Suspending Fluid
  • Deionised water.
    • Drying Time
  • The inoculated instrument tray was allowed to dry out naturally at room temperature for 24 h in a dark cupboard.
    • Scrunch Time
  • 15 seconds.
    • Wipe Time
  • 30 seconds.
    • Control
  • 1. Sterile deionised water/Kimcare Medical Wipe (Kimberly-Clark). The wipe was immersed in water and then squeezed with the fingers to remove excess fluid.
    • Results
  • TABLE 6
    Inoc- Mixing Wiping
    ulum Disinfectant/ time time Viable Count
    Exp. (spores) detergent (sec) (sec) Surface Wipe
    1 106 ClO2 15 30 0 0
    2 106 Water 15 30 2.0 × 102 2.1 × 102
    3 108 ClO2 15 30 4.8 × 102 1.3 × 102
    4 108 Water 15 30 6.6 × 104 1.9 × 105
  • TABLE 7
    Mixing Wipe Total number of
    Inoculum Disinfectant/ time time spores recovered
    Exp. (spores) detergent (sec) (sec) Surface1 Wipe2
    1 106 ClO2 15 30 0 0
    2 106 Water 15 30 4.0 × 103 8.4 × 103
    3 108 ClO2 15 30 9.6 × 103 5.2 × 103
    4 108 Water 15 30 1.3 × 106 7.6 × 106
    1Viable Count in Table 1 × 20 (0.5 ml of 10 ml neutraliser plated out).
    2Viable Count in Table 1 × 40 (0.5 ml of 20 ml neutraliser plated out).
    • Interpretation of Results
  • 1. Spores dried out for 24 h at room temperature on a stainless steel test surface were not easy to dislodge using a Medical Wipe saturated with deionised water. With the 106 inoculum the recovery was 4.0−8.4×103 spores leaving 2-3 log10 spores on the surface (assuming no mortality). With the 108 inoculum the recovery was 1.3−7.6×106 spores leaving 1-2 logic spores on the surface.
  • 2. ClO2 Wipes were effective in killing/removing spores dried out for 24 h at room temperature on the stainless steel test surface. With the 106 inoculum, no spores were recovered from either the surface or wipe which represents a 3-4 logic reduction on both the surface and wipe. With the 108 inoculum, a 2-3 log10 reduction of spores was achieved on the surface and a 3-4 log10 reduction on the wipe.
  • Thus, the invention provides a sterilant system which can be prepared in situ and which provides bactericidal, fungicidal, virucidal, and sporicidal fabrics. The system is particularly useful for sterilising wipes and for the dressing of wounds and ulcers.
  • To promote and accelerate the production of ClO2 from the solutions we have found that acetic anhydride and ascorbic acid may advantageously be employed together as additives in Solution A. A preferred concentration for each additive is 0.4%
  • It is appreciated that certain features of the invention which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention which are, for brevity, described in the context of a single embodiment, may also be provided separately, or in any suitable combination. It is to be recognized that various alterations, modifications, and/or additions may be introduced into the constructions and arrangements of parts described above without departing from the spirit and scope of the present invention. As used herein, the indefinite articles ‘a’ and ‘an’ connote ‘one or more’ unless the context requires otherwise.

Claims (25)

I claim:
1. A two-part sterilant system comprising:
(a) a first part comprising a first reagent in a carrier medium; and
(b) a second part which is miscible with the first part and which comprises a second reagent in a carrier medium;
wherein the first reagent and the second reagent will react when mixed to provide a sterilising composition;
wherein the first part is a fluid which includes a foam promoter and is contained in a trigger-operated foam dispenser constructed for dispensing the first part as foam;
wherein the second part is absorbed or impregnated in at least one fabric wipe containing an aqueous fluid in a sealed container.
2. A sterilant system according to claim 1, wherein the at least one fabric wipe comprises a plurality of fabric wipes, each of which is provided in its own separate sealed sachet.
3. A sterilant system according to claim 1, wherein at least one of the first part and the second part includes an indicator reagent that changes colour when the parts are mixed together.
4. A sterilant system according to claim 3, wherein the first part and the second part have a different pH and wherein the indicator reagent changes colour in response to a change in pH when the parts are mixed.
5. A sterilant system according to claim 1, wherein one of the first part and the second part comprises a solution containing sodium chlorite or sodium chlorate and the other comprises an acidic solution.
6. A sterilant system according to claim 5, wherein the acidic solution comprises a solution of citric acid, sorbic acid and boric acid.
7. A sterilant system according to claim 1, wherein the foam promoter is present in an amount from 0.1 to 50% w/w of said first part.
8. A sterilant system according to claim 7, wherein said foam promoter is present in an amount from 3 to 6% w/w of said first part.
9. A sterilant system according to claim 1, wherein one of the first part and the second part further comprises from 0.1 to 50% w/w of a humectant.
10. A sterilant system according to claim 1, wherein said humectant is present in an amount from 1 to 3% w/w of said first part or said second part.
11. A sterilant system according to claim 1, wherein when equal weights of the first part and the second part are mixed they provide a sterilising composition having a pH of from 4.5 to 6.5.
12. A sterilant system according to claim 5, wherein the first part comprises said solution of sodium chlorite or sodium chlorate.
13. A sterilant system according to claim 12, wherein said first part comprises a solution of sodium chlorite and said acidic solution comprises an aqueous mixture of citric acid, sorbic acid, boric acid, and a buffer.
14. A sterilant system according to claim 1, wherein one of the first reagent and the second reagent comprises chlorite and the other comprises hypochlorite.
15. A sterilant system according to claim 1, wherein one of the first reagent and the second reagent comprises chlorate and the other comprises a peroxide and an acid.
16. A sterilant system according to claim 1, wherein the at least one fabric wipe comprises a plurality of fabric wipes interleaved in a resealable container.
17. A two-part sterilant system comprising:
(a) a first part comprising a first reagent in a carrier medium; and
(b) a second part which is miscible with the first part and which comprises a second reagent in a carrier medium;
wherein the first reagent and the second reagent will react when mixed to provide a sterilising composition;
wherein the first part is a gel and is contained in a trigger-operated dispenser constructed for dispensing the first part as a gel;
wherein the second part is absorbed or impregnated in at least one fabric wipe containing an aqueous fluid in a sealed container.
18. A sterilant system according to claim 17, wherein the at least one fabric wipe comprises a plurality of fabric wipes, each of which is provided in its own separate sealed sachet.
19. A sterilant system according to claim 17 wherein the at least one fabric wipe comprises a plurality of fabric wipes interleaved in a resealable container.
20. A two-part wound-dressing system comprising:
(a) a first part comprising a first reagent in a carrier medium; and
(b) a second part which is miscible with the first part and which comprises a second reagent in a carrier medium;
wherein the first reagent and the second reagent will react when mixed to provide a sterilising composition;
wherein the first part is a fluid which includes a foam promoter and is contained in a trigger-operated foam dispenser constructed for dispensing the first part as a foam; wherein the second part is absorbed or impregnated in at least one fabric wound dressing containing an aqueous fluid in a sealed container.
21. A wound-dressing system according to claim 20, wherein the at least one fabric wound dressing comprises a plurality of fabric wound dressings, each of which is provided in its own separate sealed sachet.
22. A wound-dressing system according to claim 20, wherein the at least one fabric wound dressing comprises a plurality of fabric wound dressings interleaved in a resealable container.
23. A two-part wound-dressing system comprising:
(a) a first part comprising a first reagent in a carrier medium; and
(b) a second part which is miscible with the first part and which comprises a second reagent in a carrier medium;
wherein the first reagent and the second reagent will react when mixed to provide a sterilising composition;
wherein the first part is contained in a pump dispenser constructed for dispensing the first part as a gel;
wherein the second part is absorbed or impregnated in at least one fabric wound dressing containing an aqueous fluid in a sealed container.
24. A wound-dressing system according to claim 23, wherein the at least one fabric wound dressing comprises a plurality of fabric wound dressings, each of which is provided in its own separate sealed sachet.
25. A wound-dressing system according to claim 23, wherein the at least one fabric wound dressing comprises a plurality of fabric wound dressings interleaved in a resealable container.
US14/165,076 2004-09-07 2014-01-27 Sterilant system Abandoned US20140142489A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/165,076 US20140142489A1 (en) 2004-09-07 2014-01-27 Sterilant system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/935,651 US8642054B2 (en) 2004-09-07 2004-09-07 Sterilant system
US14/165,076 US20140142489A1 (en) 2004-09-07 2014-01-27 Sterilant system

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/935,651 Continuation US8642054B2 (en) 2004-09-07 2004-09-07 Sterilant system

Publications (1)

Publication Number Publication Date
US20140142489A1 true US20140142489A1 (en) 2014-05-22

Family

ID=35996519

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/935,651 Active 2026-04-12 US8642054B2 (en) 2004-09-07 2004-09-07 Sterilant system
US14/165,076 Abandoned US20140142489A1 (en) 2004-09-07 2014-01-27 Sterilant system

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/935,651 Active 2026-04-12 US8642054B2 (en) 2004-09-07 2004-09-07 Sterilant system

Country Status (1)

Country Link
US (2) US8642054B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017212024A1 (en) 2016-06-10 2017-12-14 Alethia Life Sciences Ag Chlorine dioxide disinfecting cloth
US10285400B2 (en) 2014-09-09 2019-05-14 Lonza Inc. Disinfectant composition containing quaternary ammonium compounds

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2807723A1 (en) * 2010-08-13 2012-02-16 Servet Buyuktimkin Foamable compositions of stabilized chlorite
US9394637B2 (en) 2012-12-13 2016-07-19 Jacob Holm & Sons Ag Method for production of a hydroentangled airlaid web and products obtained therefrom
US10986841B2 (en) 2018-11-06 2021-04-27 The Clorox Company Bleach compositions
US10898602B2 (en) * 2019-01-29 2021-01-26 James Allen Kodak Alcohol vapor deodorization system
US11845916B2 (en) 2020-06-24 2023-12-19 The Clorox Company Burstable sporicidal cleaning wipe system containing stabilized hypochlorite

Family Cites Families (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2833624A (en) 1956-10-02 1958-05-06 Du Pont Production of chlorine dioxide
US3568627A (en) 1969-12-24 1971-03-09 Irwin Selinger Combined record card and sterilization indicator
US3933274A (en) 1972-09-11 1976-01-20 Lever Brothers Company Product for the treatment of cellulosic fabrics
US4013761A (en) 1976-01-23 1977-03-22 Olin Corporation Chlorine dioxide generation
US4330531A (en) 1976-03-26 1982-05-18 Howard Alliger Germ-killing materials
USRE31779E (en) 1976-03-26 1984-12-25 Alcide Corporation Germ-killing composition and method
GB2004475B (en) 1977-09-22 1982-01-20 Hemlab Ag Preparation of hazardous chemical compositions
FR2417445A2 (en) 1978-02-15 1979-09-14 Vittel Eaux Min CONTAINER IN SYNTHETIC, THIN AND FLEXIBLE MATERIAL
CH636297A5 (en) 1979-04-20 1983-05-31 Fischer Ag Georg DEVICE FOR DOSING AND MIXING LIQUID TWO-COMPONENT PLASTICS.
US4705461A (en) 1979-09-19 1987-11-10 Seeger Corporation Two-component metering pump
US4345716A (en) 1980-07-21 1982-08-24 The Pharmasol Corporation Sachet
US4789100A (en) 1980-11-04 1988-12-06 Adhesive Engineering Company Multiple fluid pumping system
DE3121075A1 (en) 1981-05-27 1982-12-23 Wischerath & Schreiner KG, 8744 Mellrichstadt DONOR
ATE18626T1 (en) 1981-12-07 1986-04-15 Alcide Co Ltd GERMICIDAL COMPOSITION.
DE3221589C2 (en) 1982-06-08 1984-12-06 Franz 4834 Harsewinkel Böhnensieker Device for the automatic production of cleaning water
NO154039C (en) 1983-02-24 1986-07-09 Karl H Hoeie MIXING AND EXHAUSTING APPLIANCES FOR LIQUIDS, POTENTIAL POWDER AND LIQUID.
US4940701A (en) 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
US4534952A (en) 1984-02-24 1985-08-13 Erco Industries Limited Small scale generation of chlorine dioxide for water treatment
US4689215A (en) 1984-07-30 1987-08-25 Ratcliff Perry A Method and composition for prevention and treatment of oral disease
FR2569779A1 (en) 1984-08-31 1986-03-07 Lesaint Michel Metering injection device and irrigation installation comprising the application thereof
US4646973A (en) * 1985-08-07 1987-03-03 The Clorox Company Impingement foamer
DE3544016A1 (en) 1985-12-13 1987-06-19 Kopperschmidt Mueller & Co PUMP ARRANGEMENT FOR THE DOSED DELIVERY OF AT LEAST TWO COMPONENTS
US4978530A (en) 1986-05-02 1990-12-18 Health Care Products, Inc. Sanitized, disinfected and sporicidal articles, and processes for sanitizing, disinfecting and rendering objects sporicidal
DE3714699A1 (en) 1986-05-06 1988-01-07 Willi Dipl Ing Benz Spray device connected to a pressurised-water line
US4854501A (en) 1986-09-11 1989-08-08 Fannie Ricci Fragrance sack
JPS63106379A (en) 1986-10-23 1988-05-11 Sunstar Giken Kk Pump system for transferring fluid under pressure
US4891216A (en) * 1987-04-14 1990-01-02 Alcide Corporation Disinfecting compositions and methods therefor
US4906488A (en) 1987-05-01 1990-03-06 Arcade, Inc. Modification of permeant
GB8712285D0 (en) 1987-05-23 1987-07-01 Procter & Gamble Laundry products
US4789166A (en) 1987-09-14 1988-12-06 Microdot Inc. Rotary shaft wave seal
DE3737350A1 (en) 1987-11-04 1989-05-24 Kopperschmidt Mueller & Co PUMP ARRANGEMENT WITH DOUBLE PUMP
US5141803A (en) * 1988-06-29 1992-08-25 Sterling Drug, Inc. Nonwoven wipe impregnating composition
JP2698108B2 (en) 1988-07-18 1998-01-19 三洋電機株式会社 Sterilizer in beverage dispenser
GB8819969D0 (en) 1988-08-23 1988-09-21 Fibre Treatments Holdings Ltd Disinfecting/bleaching tissue
US5447684A (en) 1988-10-03 1995-09-05 Williams; Robert M. Sterilization devices, sporicidal compositions, sterilization methods, and devices for reducing surface tension
US5811113A (en) 1989-04-27 1998-09-22 Cancer Technologies, Inc. Method and composition for deactivating HIV infected blood and for deactivating and decolorizing anticancer drugs
NL8901877A (en) 1989-07-20 1991-02-18 Airspray Int Bv MIXING CHAMBER FOR MIXING A GASEOUS AND LIQUID COMPONENT, METHOD FOR FORMING TIGHT CHANNELS, AND BODY OR ARTICLE ACCORDING THAT METHOD.
US5091107A (en) 1989-10-20 1992-02-25 The Drackett Company Chlorine dioxide generating device
US5126070A (en) 1989-10-20 1992-06-30 The Drackett Company Chlorine dioxide generator
US5227168A (en) 1989-11-21 1993-07-13 Bruce Barber Method of treating a wound
US5133483A (en) 1990-08-23 1992-07-28 Viking Industries Metering system
GB9020559D0 (en) 1990-09-20 1990-10-31 Keymed Medicals & Ind Equip Cleaning and disinfecting medical instruments
US5152461A (en) 1990-10-01 1992-10-06 Proctor Rudy R Hand operated sprayer with multiple fluid containers
US5204081A (en) 1991-05-03 1993-04-20 Rio Linda Chemical Co., Ltd. Process for the generation of chlorine dioxide
US5232632A (en) * 1991-05-09 1993-08-03 The Procter & Gamble Company Foam liquid hard surface detergent composition
DE4120644C1 (en) 1991-06-22 1993-03-25 Raimund Andris Gmbh & Co Kg, 7730 Villingen-Schwenningen, De
GB9118711D0 (en) 1991-08-31 1991-10-16 Smithkline Beecham Plc Novel device
US5146944A (en) 1991-10-03 1992-09-15 Dowelanco Dual pump metering dilution apparatus
DE4134494A1 (en) 1991-10-18 1993-04-22 Wagner Wilhelm Wiwa Delivery and dosing assembly for static mixer for e.g. paint - has pressurised supply with separate drives for each component
US5197636A (en) 1992-02-03 1993-03-30 Allergan, Inc. Fast activation chlorine dioxide delivery apparatus
JP3154429B2 (en) * 1992-03-10 2001-04-09 株式会社リコー Information processing apparatus and method for image encoding processing
US5518675A (en) 1993-05-12 1996-05-21 York Chemical Corporation Method for intermixing comminuted dried materials
CA2107523C (en) 1993-10-01 2004-05-04 Gary D. Langeman Plural component delivery system
DE4400100A1 (en) 1994-01-04 1995-07-06 Aro S A Nv Delivery device
EP0748242A4 (en) 1994-02-28 1998-11-18 Incline Technologies Inc Method and system for cleansing the skin
WO1995027472A1 (en) 1994-04-07 1995-10-19 Richter Jon L Oral rinse and method of treating halitosis
US6007772A (en) 1994-10-06 1999-12-28 Green; Bruce Philip Cold sterilant solution
GB9420201D0 (en) 1994-10-06 1994-11-23 Green Bruce P Cold sterilant solution
US5647506A (en) * 1995-05-26 1997-07-15 Nice-Pak Products, Inc. Readily openable pop-up dispenser for moist tissues
US5649647A (en) 1995-08-10 1997-07-22 Kodarar; Joseph Transfer pump for chlorinated liquid
GB2304706B (en) 1995-09-01 1999-06-30 Feedwater Treatment Services L Preparation and use of novel biocidal solutions
US5755865A (en) 1996-03-25 1998-05-26 The New Paraho Corporation Asphalt rejuvenater and recycled asphalt composition
US6484879B2 (en) 1997-04-07 2002-11-26 Syngenta Crop Protection, Inc. Water soluble packaging system and method
US5721521A (en) 1996-08-05 1998-02-24 Lucent Technologies Inc. Notch-enhancement in band-reject filters
US5958536A (en) 1997-03-06 1999-09-28 The Challenge Printing Company Self-adhesive label with detachable sticker
US6306812B1 (en) 1997-03-07 2001-10-23 Procter & Gamble Company, The Bleach compositions containing metal bleach catalyst, and bleach activators and/or organic percarboxylic acids
US5895638A (en) 1997-03-20 1999-04-20 Akzo Nobel N.V. Method of producing chlorine dioxide
US6431189B1 (en) 1997-06-02 2002-08-13 700303 Alberta Ltd. Apparatus for and method of disinfecting hands
US6013614A (en) 1997-08-18 2000-01-11 Mahdessian; John Comprehensive stain removal kit
GB9720249D0 (en) 1997-09-24 1997-11-26 Littlejohn Graham M Disinfection process and product
OA11933A (en) 1998-03-18 2006-04-12 Redmond Sanford Tubelike dispenser package and integral outlet formed from a single sheet.
US5984089A (en) 1998-11-30 1999-11-16 Dotson; Richard Scott Prepackaged contact lens wearer hand neutralizing towelette and contact lens rewetting agent
US6753306B2 (en) 1998-12-23 2004-06-22 Joseph J. Simpson Germicidal and disinfectant composition
WO2000056203A1 (en) 1999-03-25 2000-09-28 Steris Inc. Decontamination system for flexible endoscopes
US7070710B1 (en) 1999-06-11 2006-07-04 Eka Chemicals Inc. Chemical composition and method
US6669387B2 (en) 1999-10-08 2003-12-30 The Procter & Gamble Company Distributing substance onto a target surface
JP2001129041A (en) 1999-11-09 2001-05-15 Akira Fukui Dead body placing implement set
DE19956186A1 (en) 1999-11-22 2001-05-23 Krones Ag Packaging container sterilization process, comprises using a mixing nozzle to produce a disinfectant - steam mixt which is then sprayed onto the container surfaces.
WO2001047705A1 (en) 1999-12-28 2001-07-05 Kimberly-Clark Worldwide, Inc. Controlled release anti-microbial wipe for hard surfaces
JP5382970B2 (en) 2000-03-02 2014-01-08 グラコ ミネソタ インコーポレーテッド Electronic multi-component blender
US6624130B2 (en) 2000-12-28 2003-09-23 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Laundry product
US20030068454A1 (en) 2001-05-04 2003-04-10 Smith Carolyn J. Packaged pre-moistened wipes and method for cleaning breasts during nursing regimen
US6524624B1 (en) * 2001-05-16 2003-02-25 Alcide Corporation Two-part disinfecting systems and compositions and methods related thereto
JP4006019B2 (en) 2001-06-25 2007-11-14 アクゾ ノーベル エヌ．ブイ． Chlorine dioxide production method
US6696047B2 (en) 2001-09-13 2004-02-24 The Procter & Gamble Company Stable oral care compositions comprising chlorite
EP1310263A1 (en) 2001-11-09 2003-05-14 Chemische Fabrik Dr. Weigert Gmbh & Co.Kg. Process and kit for machine cleaning and disinfecting medical instruments
JP4012062B2 (en) 2002-01-22 2007-11-21 耕平 青柳 Methods for cleaning and sterilizing used medical devices
US20030216281A1 (en) 2002-05-17 2003-11-20 The Clorox Company Hard surface cleaning composition
US20040109853A1 (en) 2002-09-09 2004-06-10 Reactive Surfaces, Ltd. Biological active coating components, coatings, and coated surfaces
US7048308B2 (en) 2003-04-04 2006-05-23 Ncr Corporation Excisable pharmaceutical label
US20050159063A1 (en) 2004-01-16 2005-07-21 Bernard Hill Disposable cleaning substrate
US20050210615A1 (en) * 2004-03-29 2005-09-29 Ramachandra Shastry Oral care method

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10285400B2 (en) 2014-09-09 2019-05-14 Lonza Inc. Disinfectant composition containing quaternary ammonium compounds
WO2017212024A1 (en) 2016-06-10 2017-12-14 Alethia Life Sciences Ag Chlorine dioxide disinfecting cloth
DE102016007081A1 (en) 2016-06-10 2017-12-14 Alethia Life Sciences Ag Chlorine dioxide disinfection cloth
US11518967B2 (en) 2016-06-10 2022-12-06 Alethia Life Sciences Ag Chlorine dioxide disinfecting cloth

Also Published As

Publication number Publication date
US8642054B2 (en) 2014-02-04
US20060051387A1 (en) 2006-03-09

Similar Documents

Publication Publication Date Title
US8080216B2 (en) Decontamination system
US20140142489A1 (en) Sterilant system
EP1648523B8 (en) Sterilant system
EP1843795B1 (en) Sterilant system
AU2004319251B2 (en) Decontamination system
US20140057987A1 (en) Disinfectant Spray with Indicator
US20070231247A1 (en) Method for Diluting Hypochlorite
CA2763063A1 (en) Hand sanitizer
CN110477792A (en) A kind of nonalcoholic wet tissue and preparation method thereof can be used for breathing mask cleaning-sterilizing
EP0609106A1 (en) A glutaraldehyde composition
CN103202826A (en) Benzalkonium chloride and sodium bicarbonate composite disinfectant
GB2404337A (en) Two-part sterilant system
AU2020291943A1 (en) Compositions, kits, methods and uses for preventing microbial growth
RU2203094C1 (en) Disinfectant
TW201803601A (en) Two-part cleaning and/or disinfecting system

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION